SOVIHEP V 28 TABLETS | Sofosbuvir 400mg + Velpatasvir 100mg
SOVIHEP V Bottle of 28 Tablets contains Sofosbuvir 400 mg and Velpatasvir 100 mg, a prescription antiviral combination used to treat chronic hepatitis C infection across all major HCV genotypes.
SOVIHEP V Bottle of 28 Tablets
SOVIHEP V (Sofosbuvir 400 mg + Velpatasvir 100 mg): Comprehensive Guide and Benefits
Introduction to SOVIHEP V
SOVIHEP V: Pan-Genotypic Antiviral Therapy for Chronic Hepatitis C
SOVIHEP V is a prescription-only antiviral medicine containing Sofosbuvir 400 mg and Velpatasvir 100 mg. This fixed-dose combination is indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults and is effective against all major HCV genotypes (1–6) when used as prescribed by a healthcare professional.
Sofosbuvir and Velpatasvir work together to stop viral replication, helping eliminate the hepatitis C virus from the body. Most treatment courses last 12 weeks, although some patients may require a different duration depending on liver status and previous treatment history.
Key Benefits of SOVIHEP V
Treats chronic hepatitis C infection across all major genotypes.
High cure rates when taken as prescribed.
Convenient once-daily oral tablet.
Helps prevent progression to liver cirrhosis and liver-related complications.
Suitable for many treatment-naïve and treatment-experienced patients under specialist supervision.
How SOVIHEP V Works
Sofosbuvir inhibits the NS5B RNA-dependent RNA polymerase, while Velpatasvir inhibits the NS5A protein required for viral replication and assembly. By targeting two essential viral proteins, the combination effectively suppresses hepatitis C virus replication and enables viral clearance.
Usage Instructions
Take exactly as prescribed by your hepatologist or physician.
Swallow one tablet whole with water.
May be taken with or without food.
Take the medicine at the same time every day.
Complete the full prescribed treatment course.
Do not miss doses, as this may reduce treatment effectiveness.
Medicinal Advantages
Pan-genotypic treatment for hepatitis C.
High sustained virologic response (SVR) rates in appropriate patients.
Once-daily fixed-dose regimen improves treatment adherence.
Well-established antiviral combination recommended in international treatment guidelines.
Helps reduce the risk of long-term liver complications after successful treatment.
NOTE: SOVIHEP V is a prescription-only antiviral medicine. Liver function tests and viral load monitoring should be performed before, during, and after treatment as advised by your healthcare provider.
Off-Label Uses
SOVIHEP V should primarily be used for its approved indication of chronic hepatitis C. Any alternative use should only be under specialist supervision.
Expert Advice
Take the medicine every day without missing doses.
Inform your doctor about all medicines you are taking.
Avoid alcohol to help protect liver health.
Attend all scheduled follow-up appointments and blood tests.
Do not stop treatment without consulting your physician.
Precautions
Liver Disease
Patients with advanced liver disease require specialist assessment before starting treatment.
Kidney Function
Patients with severe kidney impairment should use the medicine only under medical supervision.
Pregnancy & Breastfeeding
The safety of Sofosbuvir/Velpatasvir during pregnancy has not been fully established. Use only if prescribed by your healthcare provider. Discuss breastfeeding with your doctor before starting treatment.
Drug Interactions
Inform your doctor if you are taking:
Amiodarone.
Rifampicin or rifabutin.
Carbamazepine or phenytoin.
St. John's Wort.
Certain antacids or proton pump inhibitors.
HIV medicines.
Existing Medical Conditions
Tell your healthcare provider if you have:
Hepatitis B infection.
Liver cirrhosis.
Kidney disease.
HIV co-infection.
History of liver transplantation.
Storage Instructions
Store below 30°C.
Keep in the original bottle with the lid tightly closed.
Protect from moisture and direct sunlight.
Keep out of reach of children.
Frequently Asked Questions (FAQs)
Q: What is SOVIHEP V used for?
A: It is used to treat chronic hepatitis C virus (HCV) infection in adults across all major HCV genotypes.
Q: What are the active ingredients?
A: Each tablet contains Sofosbuvir 400 mg and Velpatasvir 100 mg.
Q: How long is the treatment course?
A: Most patients take one tablet daily for 12 weeks, although some may require a different duration depending on clinical factors.
Q: Can SOVIHEP V be taken with food?
A: Yes. It may be taken with or without food.
Q: What are the common side effects?
A: Common side effects include headache, fatigue, nausea, diarrhea, insomnia, and anemia. Most are mild and improve as treatment continues.
Q: Can I stop taking the medicine once I feel better?
A: No. Complete the full prescribed course to maximize the chance of curing the infection and reducing the risk of treatment failure.
Q: Is SOVIHEP V available without a prescription?
A: No. It is a prescription-only antiviral medicine and should be used under specialist medical supervision.
Product Tags
SOVIHEP V, SOVIHEP V 28 Tablets, Sofosbuvir 400 mg, Velpatasvir 100 mg, Sofosbuvir Velpatasvir Tablets, Hepatitis C Medicine, Chronic Hepatitis C Treatment, HCV Antiviral, Pan-Genotypic Hepatitis C Therapy, NS5A Inhibitor, NS5B Polymerase Inhibitor, Prescription Antiviral Medicine, Liver Disease Treatment, HCV Genotype 1 to 6 Treatment, Sofosbuvir Velpatasvir Combination, Oral Antiviral Tablet, Hepatitis C Virus Therapy, Zydus SOVIHEP V, 28 Tablet Bottle, HCV Treatment Medicine
